Long-Term Indebtedness: Qiagen NV (QGEN)

Brandmark of Qiagen NV (QGEN)

Qiagen N.V. is implementing software robots for digital genetic analysis, reaching a peak in production automation. Strategic partnerships with scientific centers are accelerating the development of diagnostic systems. Complex medical logistics for reagents increase costs while ensuring test accuracy. The company's long-term debt ratio reflects the dynamics of its credit load, with the indicator currently standing at 1.63.

Company Long-Term Debts: Qiagen N.V. (QGEN) for 07/04/2022 - 10/31/2026

Qiagen Group (QGEN) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price qiagen.com|QGEN - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Qiagen|QGEN - Enterprise Value
- company book value details:
Net Assets per Share Qiagen|QGEN - Book Capitalization|Market Capitalization to Book Value Ratio qiagen.com|QGEN - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital Ratio Qiagen N.V.|QGEN - Long-Term Debt to Capital|Current Liabilities to Capital Qiagen Corp|QGEN - Company Debts|Debt to Book Value Ratio Qiagen|QGEN - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Qiagen|Immediate Liquidity Ratio qiagen.com
- company profitability and valuation multiples indicators:
QGEN - Net Income
Analysis of all company metrics:qiagen.com - QGEN
Core merchandise of Qiagen

Long-term debt reflects the aggregate of credit obligations with a maturity exceeding one year. This metric is calculated by aggregating confirmed borrowings and reacts sensitively to bond issuances or major bank loans. By analyzing the magnitude of the issuer's long-term liabilities, an investor assesses financial leverage and the stability of the capital structure. For Qiagen N.V. (QGEN), this resource serves as a tool for maintaining technological leadership in molecular diagnostics under the leadership of Thierry Bernard.

Competitor analysis for Qiagen N.V.

Company Long-Term Debts Tempus Labs TEM|IONS - Company Long-Term Debt|Long-Term Indebtedness Repligen Corp (RGEN)|RNA: Company Long-Term Debts|CRSP - Long-Term Debt Volume|WGS (GeneDx Holdings Corp.) - Company Long-Term Debts|Company Long-Term Debts ultragenyx.com|Company Long-Term Debts BEAM|Sarepta Therapeutics (SRPT) - Long-Term Indebtedness|Company Long-Term Debts TWST (Twist Bio)|10x (TXG) - Long-Term Debt|NTLA - Company Long-Term Debt|STOK (stoketherapeutics.com) - Company Long-Term Indebtedness|BLFS (BioLife Solutions) - Company Long-Term Liabilities|Wave Life Sciences Ltd - Company Long-Term Loans and Borrowings|Company Long-Term Debt Maze Tx|Company Long-Term Indebtedness SION (Sionna Corp)|Company Long-Term Liabilities PRME (Prime Medicine, Inc.)|Long-Term Debt Volume tayshagtx.com|uniQure - Company Long-Term Liabilities|MeiraGTx Holdings - Company Long-Term Debt|RGNX: Company Long-Term Liabilities|Long-Term Debt Volume Solid Corp SLDB|Ocugen, Inc. (OCGN) - Company Long-Term Debt|Long-Term Indebtedness pacb.com PACB|BNTC (Benitec Biopharma) - Company Long-Term Debts|DSGN - Long-Term Indebtedness|Company Long-Term Debts RCKT|FDMT - Long-Term Debt|Company Long-Term Debt Lexeo Therapeutics, Inc. LXEO|KRRO: Company Long-Term Indebtedness|Editas Medicine - Company Long-Term Debts|SLN (Silence Therapeutics PLC) - Company Long-Term Indebtedness|proqr.com (PRQR) - Company Long-Term Debt|Company Long-Term Indebtedness CDXS|SGMO (Sangamo Therapeutics) - Company Long-Term Debts|Company Long-Term Debts Nautilus Biotechnology Inc|Company Long-Term Debt Metagenomi (MGX)|Precision BioSciences Inc. (DTIL) - Long-Term Indebtedness|Company Long-Term Debts GBIO (Generation Bio)|Long-Term Debt Volume Boundless Bio Inc (BOLD)|Exicure Corp - Company Long-Term Debts|IMNN - Company Long-Term Debts|PHIO: Company Long-Term Debts|Long-Term Indebtedness Mustang Bio MBIO|RNAZ (TransCode Therapeutics Inc.) - Company Long-Term Debts|Long-Term Debt Bionano BNGO|Company Long-Term Debt Applied DNA Sciences (APDN)|bluebirdbio.com - Company Long-Term Indebtedness|ImmunoPrecise Antibodies Ltd. - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings OMGA|OMIC - Company Long-Term Debt|RGLS (Regulus) - Company Long-Term Indebtedness|SYRS (Syros Pharmaceuticals) - Company Long-Term Liabilities|TBIO - Long-Term Debt Volume|Company Long-Term Liabilities TCON|Company Long-Term Debt UBX